Picture of Eiko Lifesciences logo

540204 Eiko Lifesciences Income Statement

0.000.00%
in flag iconLast trade - 00:00
Basic MaterialsSpeculativeMicro CapNeutral

Annual income statement for Eiko Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinal
Revenue
Total Revenue0120254183
Cost of Revenue
Gross Profit013.828.322.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses2.31115247180
Operating Profit-2.314.67.333.22
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes1.38.339.4210.3
Provision for Income Taxes
Net Income After Taxes1.286.147.067.69
Net Income Before Extraordinary Items
Net Income1.286.147.067.69
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1.286.147.067.69
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.291.390.7830.797
Dividends per Share